References
- Hudlucky M. Oxidations in organic chemistry. Washington (DC): American Chemical Society; 1990.
- Ullrich R, Hofrichter M. Enzymatic hydroxylation of aromatic compounds. Cell. Mol. Life Sci. 2007;64:271–293.10.1007/s00018-007-6362-1
- Urlacher V, Schmid R. Recent advances in oxygenase-catalyzed biotransformations. Curr. Opin. Chem. Biol. 2006;10:156–161.10.1016/j.cbpa.2006.02.001
- Urlacher V, Eiben S. Cytochrome P450 monooxygenases: perspectives for synthetic application. Trends Biotechnol. 2006;24:324–330.10.1016/j.tibtech.2006.05.002
- Stewart J. Cyclohexanone monooxygenase: a useful reagent for asymmetric Baeyer-Villiger reactions. Curr. Org. Chem. 1998;2:195–216.
- Hibi M, Kawashima T, Kasahara T, Sokolov PM, Smirnov SV, Kodera T, Sugiyama M, Shimizu S, Yokozeki K, Ogawa J. A novel Fe(II)/α-ketoglutarate-dependent dioxygenase from Burkholderia ambifaria has β-hydroxylating activity of N-succinyl L-leucine. Lett. Appl. Microbiol. 2012;55:414–441.
- Hibi M, Kawashima T, Kodera T, Smirnov SV, Sokolov PM, Sugiyama M, Shimizu S, Yokozeki K, Ogawa J. Characterization of Bacillus thuringiensis L-isoleucine dioxygenase for production of useful amino acids. Appl. Environ. Microbiol. 2011;77:6926–6930.10.1128/AEM.05035-11
- Hibi M, Kawashima T, Sokolov PM, Smirnov SV, Kodera T, Sugiyama M, Shimizu S, Yokozeki K, Ogawa J. L-leucine 5-hydroxylase of Nostoc punctiforme is a novel type of Fe(II)/α-ketoglutarate-dependent dioxygenase that is useful as a biocatalyst. Appl. Microbiol. Biotechnol. 2013;97:2467–2472.10.1007/s00253-012-4136-7
- Hibi M, Kawashima T, Yajima H, Smirnov SV, Kodera T, Sugiyama M, Shimizu S, Yokozeki K, Ogawa J. Enzymatic synthesis of chiral amino acid sulfoxides by Fe(II)/α-ketoglutarate-dependent dioxygenase. Tetrahedron: Asymmetry. 2013;24:990–994.10.1016/j.tetasy.2013.07.017
- Jakubowski J, Winters K, Naganuma H, Wallentin L. Prasugrel: a novel thienopyridine antiplatelet agent. A review of preclinical and clinical studies and the mechanistic basis for its distinct antiplatelet profile. Cardiovasc. Drug Rev. 2007;25:357–374.10.1111/cdr.2007.25.issue-4
- Thijs L, Zhu J, Overeem A, Keltens R. WO 2011/110219 A1 (2011 Sep 15).
- Larkin M, Kulakov L, Allen C. Biodegradation and Rhodococcus – masters of catabolic versatility. Curr. Opin. Biotechnol. 2005;16:282–290.10.1016/j.copbio.2005.04.007